EWA
COYA icon

EverSource Wealth Advisors’s Coya Therapeutics COYA Stock Holding History

EverSource Wealth Advisors’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-76
Closed -$433 – 4303
2025
Q3 		$433 Sell
76
-53
-41% -$322 ﹤0.01% 3983
2025
Q2 		$742 Buy
+129
New +$747 ﹤0.01% 3803

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

EverSource Wealth Advisors's COYA Position: Q4 2025 in Review

EverSource Wealth Advisors sold out of Coya Therapeutics (COYA) in Q4 2025, closing a stake of 76 shares — an estimated $433 sold.

EverSource Wealth Advisors first reported a position in COYA in Q2 2025 and held it in 2 quarters. The position peaked at $742 in Q2 2025. 58 funds tracked by Wall St. Rank hold COYA as of Q4 2025.

  • EverSource Wealth Advisors reported no remaining Coya Therapeutics position as of Q4 2025 after selling out during the quarter.
  • EverSource Wealth Advisors sold 76 Coya Therapeutics shares in Q4 2025, an estimated $433.
  • EverSource Wealth Advisors first reported a position in Coya Therapeutics in Q2 2025 and held it in 2 quarters.
  • EverSource Wealth Advisors's Coya Therapeutics position peaked at $742 in Q2 2025.
  • 58 funds tracked by Wall St. Rank held Coya Therapeutics as of Q4 2025.

Based on EverSource Wealth Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.